Evofem Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EVFM and buy or sell other stocks, ETFs, and their options commission-free!About EVFM
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women.
CEOSaundra L. Pelletier
CEOSaundra L. Pelletier
Employees37
Employees37
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2007
Founded2007
Employees37
Employees37
EVFM Key Statistics
Market cap1.90M
Market cap1.90M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume53.48K
Average volume53.48K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$196.25
52 Week high$196.25
52 Week low$0.85
52 Week low$0.85
Stock Snapshot
As of today, Evofem Biosciences(EVFM) shares are valued at $1.93. The company's market cap stands at 1.9M.
On 2025-12-17, Evofem Biosciences(EVFM) stock opened at —, reached a high of —, and a low of —.
The Evofem Biosciences(EVFM)'s current trading volume is 0, compared to an average daily volume of 53.48K.
In the last year, Evofem Biosciences(EVFM) shares hit a 52-week high of $196.25 and a 52-week low of $0.85.
In the last year, Evofem Biosciences(EVFM) shares hit a 52-week high of $196.25 and a 52-week low of $0.85.
People also own
Based on the portfolios of people who own EVFM. This list is generated using Robinhood data, and it’s not a recommendation.